Chapter 2

Pharmacogenomics: Pharmacology and Toxicology in the Genomics Era

Harvey W. Mohrenweiser Ph.D.

Harvey W. Mohrenweiser Ph.D.

Biology and Biotechnology Research Program, Lawrence Livermore National Laboratory, Livermore, CA, USA

Search for more papers by this author
First published: 10 January 2003
Citations: 1

Summary

The Human Genome Project has changed biological science. Large volumes of raw data, including the sequence of the human genome, are readily accessible in public databases. The successes of the Human Genome Project have encouraged discussion of other industrial-scale data generation projects. Building from the warehouses of information, including catalogs of genes and genetic variants, gene expression profiles, protein-protein interactions and protein structures, it is expected that a focus on pharmacogenomics will facilitate rapid progress in drug development and treatment protocol design and result in significant improvements in healthcare.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.